Find Support on Your Journey

Landing Page Draft

What disease community should we include next? 

Latest News

April 22, 2021

CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment – Frontiers

April 22, 2021

Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression – Nature

April 15, 2021

Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients – Nature

March 31, 2021

A Glycolysis-Based Long Non-coding RNA Signature Accurately Predicts Prognosis in Renal Carcinoma Patients – Frontiers

March 28, 2021

Destination Amyotrophic Lateral Sclerosis – Frontiers

Looking for a Clinical Trial?

As of September 20, 2025

1109 Lung Cancer Clinical Trials are now recruiting

850 Breast Cancer Clinical Trials are now recruiting

621 Colorectal Cancer Clinical Trials are now recruiting

442 Pancreatic Cancer Clinical Trials are now recruiting

440 Prostate Cancer Clinical Trials are now recruiting

Source:  clinicaltrials.gov